Bangladesh vs Indonesia: Share of people with HIV who receive antiretroviral therapy
Bangladesh
41.0%
in 2024
Indonesia
41.0%
in 2024
Bangladesh rank
131st
Indonesia rank
131st
Share of people with HIV who receive antiretroviral therapy over time
- Bangladesh
- Indonesia
How they compare
Bangladesh currently reports 41.0% against 41.0% in Indonesia, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Indonesia ahead.
Bangladesh ranks 131st and Indonesia ranks 131st of 143 countries.
Bangladesh has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bangladesh | Indonesia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.1% | 1.1% | 0.0% | — |
| 2010s | 14.1% | 11.9% | 2.2% | Bangladesh |
| 2020s | 34.2% | 30.6% | 3.6% | Bangladesh |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of people with hiv who receive antiretroviral therapy, Bangladesh or Indonesia?
- Bangladesh, at 41.0% against 41.0% in Indonesia as of 2024.
- What is the difference in share of people with hiv who receive antiretroviral therapy between Bangladesh and Indonesia?
- 0.0%, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Indonesia?
- 25 years are reported by both, from 2000 to 2024.
- How do Bangladesh and Indonesia rank globally for share of people with hiv who receive antiretroviral therapy?
- Bangladesh ranks 131st and Indonesia ranks 131st of 143 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of people with HIV who receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.